Eli Lilly & Co. (LLY)
Last updated: 2026-10-31 21:13:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Eli Lilly & Co. (LLY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1,416.94, with a market capitalization of $1.22T and a P/E ratio of 47.30. Over the past 52 weeks, its price has ranged from $834.19 to $1,449.68. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.22T | |
$1,428.83 | |
$1,449.68 | |
$27.21 | |
$1,373.70 | |
3.86M | |
2.55M | |
47.30 | |
$1,449.68 | |
$834.19 | |
0.46% | |
2001-12-30 |
Eli Lilly & Co. (LLY) Latest Closing Stock Price
Eli Lilly & Co. (LLY) last closed at $1,373.70 as of 2026-10-30 23:59:03, unchanged from the previous close of $1,373.70.
During the latest regular trading session, LLY traded between $27.21 and $1,449.68, with a volume of 3.86M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Eli Lilly & Co. (LLY) 7-Day Stock Price Change
Over the past seven days, Eli Lilly & Co. (LLY) moved from $1,306.69 to $1,416.94, representing a gain of 8.44% ($110.25).
The stock traded between $1,257.62 and $1,449.68 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 2.94 million shares, up versus the previous seven-day period, indicating higher trading activity.
LLY 52-Week Price Position
Position in Range: 94.7%
LLY is currently trading at $1,416.94, placing it 94.7% of the way from its 52-week low of $834.19 to its 52-week high of $1,449.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Eli Lilly & Co. (LLY)?
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly & Co. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 50000 |
| CEO | David A. Ricks |
| Founded | 1876 |
| Exchange | NYSE |
| Company Website |
How to Buy Eli Lilly & Co. (LLY) Stock on MEXC
Eligible investors can buy real shares of Eli Lilly & Co. (LLY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Eli Lilly & Co. (LLY) stock price today?
2.Is LLY stock going up or down today?
3.What is LLY pre-market price?
4.What is LLY after-hours price?
5.Is LLY stock trading now?
6.Where does LLY sit relative to its 52-week high and low?
7.What sector is Eli Lilly & Co. in?
8.What is Eli Lilly & Co.'s market capitalization and where is it listed?
9.How is LLY valued in terms of P/E ratio and EPS?
10.Does Eli Lilly & Co. pay a dividend?
Explore More US Stocks
Search Stocks
LLY Stock Calculator
Estimate the value between LLY shares and USD.
LLY Shares to USD
1.00 LLY shares = 1,416.944 USD
Calculations are estimates based on the latest available price and are for reference only.


